HPV Associated Disorder Market, Global Outlook and Forecast 2022-2028

April 2022 | 68 pages | ID: H0D7966E4B7FEN
Market Monitor Global

Abstracts

HPV Associated Disorder means a series of diseases associated with HPV, either pre-disease or some of the diseases induced thereby.

This report contains market size and forecasts of HPV Associated Disorder in Global, including the following market information:

Global HPV Associated Disorder Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global HPV Associated Disorder market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Prevention Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of HPV Associated Disorder include Merck & Co., Inc, GlaxoSmithKline plc, F. Hoffmann-La Roche Ltd, Pfizer, Inc., Allergan plc, AstraZeneca plc, Biocon Ltd and Eli Lilly and Company, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the HPV Associated Disorder companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global HPV Associated Disorder Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global HPV Associated Disorder Market Segment Percentages, by Type, 2021 (%)

• Prevention
• Treatment

Global HPV Associated Disorder Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global HPV Associated Disorder Market Segment Percentages, by Application, 2021 (%)

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Global HPV Associated Disorder Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global HPV Associated Disorder Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies HPV Associated Disorder revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies HPV Associated Disorder revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Merck & Co., Inc
• GlaxoSmithKline plc
• F. Hoffmann-La Roche Ltd
• Pfizer, Inc.
• Allergan plc
• AstraZeneca plc
• Biocon Ltd
• Eli Lilly and Company

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 HPV Associated Disorder Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global HPV Associated Disorder Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL HPV ASSOCIATED DISORDER OVERALL MARKET SIZE

2.1 Global HPV Associated Disorder Market Size: 2021 VS 2028
2.2 Global HPV Associated Disorder Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top HPV Associated Disorder Players in Global Market
3.2 Top Global HPV Associated Disorder Companies Ranked by Revenue
3.3 Global HPV Associated Disorder Revenue by Companies
3.4 Top 3 and Top 5 HPV Associated Disorder Companies in Global Market, by Revenue in 2021
3.5 Global Companies HPV Associated Disorder Product Type
3.6 Tier 1, Tier 2 and Tier 3 HPV Associated Disorder Players in Global Market
  3.6.1 List of Global Tier 1 HPV Associated Disorder Companies
  3.6.2 List of Global Tier 2 and Tier 3 HPV Associated Disorder Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global HPV Associated Disorder Market Size Markets, 2021 & 2028
  4.1.2 Prevention
  4.1.3 Treatment
4.2 By Type - Global HPV Associated Disorder Revenue & Forecasts
  4.2.1 By Type - Global HPV Associated Disorder Revenue, 2017-2022
  4.2.2 By Type - Global HPV Associated Disorder Revenue, 2023-2028
  4.2.3 By Type - Global HPV Associated Disorder Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global HPV Associated Disorder Market Size, 2021 & 2028
  5.1.2 Hospital Pharmacies
  5.1.3 Retail Pharmacies
  5.1.4 Online Pharmacies
5.2 By Application - Global HPV Associated Disorder Revenue & Forecasts
  5.2.1 By Application - Global HPV Associated Disorder Revenue, 2017-2022
  5.2.2 By Application - Global HPV Associated Disorder Revenue, 2023-2028
  5.2.3 By Application - Global HPV Associated Disorder Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global HPV Associated Disorder Market Size, 2021 & 2028
6.2 By Region - Global HPV Associated Disorder Revenue & Forecasts
  6.2.1 By Region - Global HPV Associated Disorder Revenue, 2017-2022
  6.2.2 By Region - Global HPV Associated Disorder Revenue, 2023-2028
  6.2.3 By Region - Global HPV Associated Disorder Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America HPV Associated Disorder Revenue, 2017-2028
  6.3.2 US HPV Associated Disorder Market Size, 2017-2028
  6.3.3 Canada HPV Associated Disorder Market Size, 2017-2028
  6.3.4 Mexico HPV Associated Disorder Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe HPV Associated Disorder Revenue, 2017-2028
  6.4.2 Germany HPV Associated Disorder Market Size, 2017-2028
  6.4.3 France HPV Associated Disorder Market Size, 2017-2028
  6.4.4 U.K. HPV Associated Disorder Market Size, 2017-2028
  6.4.5 Italy HPV Associated Disorder Market Size, 2017-2028
  6.4.6 Russia HPV Associated Disorder Market Size, 2017-2028
  6.4.7 Nordic Countries HPV Associated Disorder Market Size, 2017-2028
  6.4.8 Benelux HPV Associated Disorder Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia HPV Associated Disorder Revenue, 2017-2028
  6.5.2 China HPV Associated Disorder Market Size, 2017-2028
  6.5.3 Japan HPV Associated Disorder Market Size, 2017-2028
  6.5.4 South Korea HPV Associated Disorder Market Size, 2017-2028
  6.5.5 Southeast Asia HPV Associated Disorder Market Size, 2017-2028
  6.5.6 India HPV Associated Disorder Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America HPV Associated Disorder Revenue, 2017-2028
  6.6.2 Brazil HPV Associated Disorder Market Size, 2017-2028
  6.6.3 Argentina HPV Associated Disorder Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa HPV Associated Disorder Revenue, 2017-2028
  6.7.2 Turkey HPV Associated Disorder Market Size, 2017-2028
  6.7.3 Israel HPV Associated Disorder Market Size, 2017-2028
  6.7.4 Saudi Arabia HPV Associated Disorder Market Size, 2017-2028
  6.7.5 UAE HPV Associated Disorder Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Merck & Co., Inc
  7.1.1 Merck & Co., Inc Corporate Summary
  7.1.2 Merck & Co., Inc Business Overview
  7.1.3 Merck & Co., Inc HPV Associated Disorder Major Product Offerings
  7.1.4 Merck & Co., Inc HPV Associated Disorder Revenue in Global Market (2017-2022)
  7.1.5 Merck & Co., Inc Key News
7.2 GlaxoSmithKline plc
  7.2.1 GlaxoSmithKline plc Corporate Summary
  7.2.2 GlaxoSmithKline plc Business Overview
  7.2.3 GlaxoSmithKline plc HPV Associated Disorder Major Product Offerings
  7.2.4 GlaxoSmithKline plc HPV Associated Disorder Revenue in Global Market (2017-2022)
  7.2.5 GlaxoSmithKline plc Key News
7.3 F. Hoffmann-La Roche Ltd
  7.3.1 F. Hoffmann-La Roche Ltd Corporate Summary
  7.3.2 F. Hoffmann-La Roche Ltd Business Overview
  7.3.3 F. Hoffmann-La Roche Ltd HPV Associated Disorder Major Product Offerings
  7.3.4 F. Hoffmann-La Roche Ltd HPV Associated Disorder Revenue in Global Market (2017-2022)
  7.3.5 F. Hoffmann-La Roche Ltd Key News
7.4 Pfizer, Inc.
  7.4.1 Pfizer, Inc. Corporate Summary
  7.4.2 Pfizer, Inc. Business Overview
  7.4.3 Pfizer, Inc. HPV Associated Disorder Major Product Offerings
  7.4.4 Pfizer, Inc. HPV Associated Disorder Revenue in Global Market (2017-2022)
  7.4.5 Pfizer, Inc. Key News
7.5 Allergan plc
  7.5.1 Allergan plc Corporate Summary
  7.5.2 Allergan plc Business Overview
  7.5.3 Allergan plc HPV Associated Disorder Major Product Offerings
  7.5.4 Allergan plc HPV Associated Disorder Revenue in Global Market (2017-2022)
  7.5.5 Allergan plc Key News
7.6 AstraZeneca plc
  7.6.1 AstraZeneca plc Corporate Summary
  7.6.2 AstraZeneca plc Business Overview
  7.6.3 AstraZeneca plc HPV Associated Disorder Major Product Offerings
  7.6.4 AstraZeneca plc HPV Associated Disorder Revenue in Global Market (2017-2022)
  7.6.5 AstraZeneca plc Key News
7.7 Biocon Ltd
  7.7.1 Biocon Ltd Corporate Summary
  7.7.2 Biocon Ltd Business Overview
  7.7.3 Biocon Ltd HPV Associated Disorder Major Product Offerings
  7.7.4 Biocon Ltd HPV Associated Disorder Revenue in Global Market (2017-2022)
  7.7.5 Biocon Ltd Key News
7.8 Eli Lilly and Company
  7.8.1 Eli Lilly and Company Corporate Summary
  7.8.2 Eli Lilly and Company Business Overview
  7.8.3 Eli Lilly and Company HPV Associated Disorder Major Product Offerings
  7.8.4 Eli Lilly and Company HPV Associated Disorder Revenue in Global Market (2017-2022)
  7.8.5 Eli Lilly and Company Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. HPV Associated Disorder Market Opportunities & Trends in Global Market
Table 2. HPV Associated Disorder Market Drivers in Global Market
Table 3. HPV Associated Disorder Market Restraints in Global Market
Table 4. Key Players of HPV Associated Disorder in Global Market
Table 5. Top HPV Associated Disorder Players in Global Market, Ranking by Revenue (2021)
Table 6. Global HPV Associated Disorder Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global HPV Associated Disorder Revenue Share by Companies, 2017-2022
Table 8. Global Companies HPV Associated Disorder Product Type
Table 9. List of Global Tier 1 HPV Associated Disorder Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 HPV Associated Disorder Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global HPV Associated Disorder Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - HPV Associated Disorder Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - HPV Associated Disorder Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global HPV Associated Disorder Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - HPV Associated Disorder Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - HPV Associated Disorder Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global HPV Associated Disorder Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global HPV Associated Disorder Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global HPV Associated Disorder Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America HPV Associated Disorder Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America HPV Associated Disorder Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe HPV Associated Disorder Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe HPV Associated Disorder Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia HPV Associated Disorder Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia HPV Associated Disorder Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America HPV Associated Disorder Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America HPV Associated Disorder Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa HPV Associated Disorder Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa HPV Associated Disorder Revenue, (US$, Mn), 2023-2028
Table 30. Merck & Co., Inc Corporate Summary
Table 31. Merck & Co., Inc HPV Associated Disorder Product Offerings
Table 32. Merck & Co., Inc HPV Associated Disorder Revenue (US$, Mn), (2017-2022)
Table 33. GlaxoSmithKline plc Corporate Summary
Table 34. GlaxoSmithKline plc HPV Associated Disorder Product Offerings
Table 35. GlaxoSmithKline plc HPV Associated Disorder Revenue (US$, Mn), (2017-2022)
Table 36. F. Hoffmann-La Roche Ltd Corporate Summary
Table 37. F. Hoffmann-La Roche Ltd HPV Associated Disorder Product Offerings
Table 38. F. Hoffmann-La Roche Ltd HPV Associated Disorder Revenue (US$, Mn), (2017-2022)
Table 39. Pfizer, Inc. Corporate Summary
Table 40. Pfizer, Inc. HPV Associated Disorder Product Offerings
Table 41. Pfizer, Inc. HPV Associated Disorder Revenue (US$, Mn), (2017-2022)
Table 42. Allergan plc Corporate Summary
Table 43. Allergan plc HPV Associated Disorder Product Offerings
Table 44. Allergan plc HPV Associated Disorder Revenue (US$, Mn), (2017-2022)
Table 45. AstraZeneca plc Corporate Summary
Table 46. AstraZeneca plc HPV Associated Disorder Product Offerings
Table 47. AstraZeneca plc HPV Associated Disorder Revenue (US$, Mn), (2017-2022)
Table 48. Biocon Ltd Corporate Summary
Table 49. Biocon Ltd HPV Associated Disorder Product Offerings
Table 50. Biocon Ltd HPV Associated Disorder Revenue (US$, Mn), (2017-2022)
Table 51. Eli Lilly and Company Corporate Summary
Table 52. Eli Lilly and Company HPV Associated Disorder Product Offerings
Table 53. Eli Lilly and Company HPV Associated Disorder Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. HPV Associated Disorder Segment by Type in 2021
Figure 2. HPV Associated Disorder Segment by Application in 2021
Figure 3. Global HPV Associated Disorder Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global HPV Associated Disorder Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global HPV Associated Disorder Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by HPV Associated Disorder Revenue in 2021
Figure 8. By Type - Global HPV Associated Disorder Revenue Market Share, 2017-2028
Figure 9. By Application - Global HPV Associated Disorder Revenue Market Share, 2017-2028
Figure 10. By Region - Global HPV Associated Disorder Revenue Market Share, 2017-2028
Figure 11. By Country - North America HPV Associated Disorder Revenue Market Share, 2017-2028
Figure 12. US HPV Associated Disorder Revenue, (US$, Mn), 2017-2028
Figure 13. Canada HPV Associated Disorder Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico HPV Associated Disorder Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe HPV Associated Disorder Revenue Market Share, 2017-2028
Figure 16. Germany HPV Associated Disorder Revenue, (US$, Mn), 2017-2028
Figure 17. France HPV Associated Disorder Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. HPV Associated Disorder Revenue, (US$, Mn), 2017-2028
Figure 19. Italy HPV Associated Disorder Revenue, (US$, Mn), 2017-2028
Figure 20. Russia HPV Associated Disorder Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries HPV Associated Disorder Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux HPV Associated Disorder Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia HPV Associated Disorder Revenue Market Share, 2017-2028
Figure 24. China HPV Associated Disorder Revenue, (US$, Mn), 2017-2028
Figure 25. Japan HPV Associated Disorder Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea HPV Associated Disorder Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia HPV Associated Disorder Revenue, (US$, Mn), 2017-2028
Figure 28. India HPV Associated Disorder Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America HPV Associated Disorder Revenue Market Share, 2017-2028
Figure 30. Brazil HPV Associated Disorder Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina HPV Associated Disorder Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa HPV Associated Disorder Revenue Market Share, 2017-2028
Figure 33. Turkey HPV Associated Disorder Revenue, (US$, Mn), 2017-2028
Figure 34. Israel HPV Associated Disorder Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia HPV Associated Disorder Revenue, (US$, Mn), 2017-2028
Figure 36. UAE HPV Associated Disorder Revenue, (US$, Mn), 2017-2028
Figure 37. Merck & Co., Inc HPV Associated Disorder Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. GlaxoSmithKline plc HPV Associated Disorder Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. F. Hoffmann-La Roche Ltd HPV Associated Disorder Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Pfizer, Inc. HPV Associated Disorder Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Allergan plc HPV Associated Disorder Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. AstraZeneca plc HPV Associated Disorder Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Biocon Ltd HPV Associated Disorder Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Eli Lilly and Company HPV Associated Disorder Revenue Year Over Year Growth (US$, Mn) & (2017-2022)